I call this meeting to order.
Welcome to meeting number 105 of the House of Commons Standing Committee on Health.
Today's meeting is taking place in a hybrid format, pursuant to the Standing Orders. To ensure that the meeting runs smoothly, I'd like to pass on some instructions to the witnesses.
Please wait until I recognize you by name before speaking. For those participating by video conference, click on the microphone icon to activate your mike, and please mute yourself when you are not speaking.
As far as interpretation is concerned, those taking part remotely using Zoom have the choice, at the bottom of their screen, between floor, English or French. Those in the room can use the earpiece and select the desired channel.
As a reminder, all comments should be addressed through the chair.
In accordance with our routine motion, I am informing the committee that all remote participants have completed the required connection tests in advance of the meeting.
Pursuant to Standing Order 108(2), the committee is resuming its study of the opioid epidemic and toxic drug crisis in Canada.
I would like to welcome the witnesses joining us today.
Appearing as an individual is Dr. Elaine Hyshka, associate professor and Canada Research Chair in Health Systems Innovation, School of Public Health, University of Alberta.
From the University of Toronto, we also have Dr. Meldon Kahan, associate professor, Department of Family Medicine.
Joining us from Simon Fraser University is Dr. Bohdan Nosyk, professor and St. Paul's Hospital CANFAR chair in HIV/AIDS Research.
Also with us is Dr. Marie-Ève Goyer, physician, Clinical and organizational support team in addiction and homelessness.
We will now proceed to opening statements. You will each have up to five minutes for your statement. We'll begin with Dr. Hyshka, followed by Dr. Kahan, Dr. Nosyk and Dr. Goyer.
Dr. Hyshka, you have the floor for five minutes.